1. Home
  2. GDO vs YI Comparison

GDO vs YI Comparison

Compare GDO & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDO
  • YI
  • Stock Information
  • Founded
  • GDO 2009
  • YI 2010
  • Country
  • GDO United States
  • YI China
  • Employees
  • GDO N/A
  • YI N/A
  • Industry
  • GDO Finance Companies
  • YI Retail-Drug Stores and Proprietary Stores
  • Sector
  • GDO Finance
  • YI Consumer Staples
  • Exchange
  • GDO Nasdaq
  • YI Nasdaq
  • Market Cap
  • GDO 86.3M
  • YI 70.0M
  • IPO Year
  • GDO N/A
  • YI N/A
  • Fundamental
  • Price
  • GDO $11.71
  • YI $7.48
  • Analyst Decision
  • GDO
  • YI
  • Analyst Count
  • GDO 0
  • YI 0
  • Target Price
  • GDO N/A
  • YI N/A
  • AVG Volume (30 Days)
  • GDO 39.4K
  • YI 12.2K
  • Earning Date
  • GDO 01-01-0001
  • YI 08-28-2025
  • Dividend Yield
  • GDO 9.81%
  • YI N/A
  • EPS Growth
  • GDO N/A
  • YI N/A
  • EPS
  • GDO N/A
  • YI N/A
  • Revenue
  • GDO N/A
  • YI $1,984,717,013.00
  • Revenue This Year
  • GDO N/A
  • YI N/A
  • Revenue Next Year
  • GDO N/A
  • YI N/A
  • P/E Ratio
  • GDO N/A
  • YI N/A
  • Revenue Growth
  • GDO N/A
  • YI N/A
  • 52 Week Low
  • GDO $11.21
  • YI $4.15
  • 52 Week High
  • GDO $13.04
  • YI $12.90
  • Technical
  • Relative Strength Index (RSI)
  • GDO 62.04
  • YI 47.47
  • Support Level
  • GDO $11.70
  • YI $7.02
  • Resistance Level
  • GDO $11.83
  • YI $7.88
  • Average True Range (ATR)
  • GDO 0.09
  • YI 0.49
  • MACD
  • GDO -0.00
  • YI -0.01
  • Stochastic Oscillator
  • GDO 63.27
  • YI 55.35

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Share on Social Networks: